Get startedLog in
    Picture of CSL logo

    CSL — CSL News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Australia's Therapeutic Goods Administration Says Seqirus To Discontinue Benpen Injection Products

    Picture of CSL logoCSL
    27/05/2026 09:01
    BRIEF-Australia's Therapeutic Goods Administration Says Seqirus To Discontinue Benpen Injection Products
    May 27 (Reuters) - Australia's Therapeutic Goods Administration:
    • SEQIRUS NOTIFIED TO DISCONTINUE ALL STRENGTHS OF BENPEN INJECTION PRODUCTS PROGRESSIVELY
    • ALTERNATIVE AUSTRALIAN-REGISTERED BENZYLPENICILLIN SODIUM INJECTION BRANDS EXPECTED TO BE AVAILABLE IN FUTURE
    • SUPPLY OF THESE BENZYLPENICILLIN SODIUM INJECTION PRODUCTS WILL CONTINUE UNTIL STOCK IS EXHAUSTED
    • BENPEN INJECTION PRODUCTS TO BE DISCONTINUED PROGRESSIVELY STARTING WITH 600MG STRENGTH FROM 30 NOV DUE TO COMMERCIAL REASONS

    Further company coverage: CSL.AX

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CSL

    See all news